The advantages of being locked - Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes

被引:27
作者
Donini, Stefano
Clerici, Marcello
Wengel, Jesper
Vester, Birte [1 ]
Peracchi, Alessio
机构
[1] Univ So Denmark, Dept Biochem & Mol Biol, Nucle Acid Ctr, DK-5230 Odense M, Denmark
[2] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy
[3] Univ So Denmark, Dept Chem, Nucle Acid Ctr, DK-5230 Odense M, Denmark
关键词
D O I
10.1074/jbc.M706993200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA-cleaving deoxyribozymes can be used for the sequence-specific knockdown of mRNAs. It was previously shown that activity of these deoxyribozymes is enhanced when their substrate-binding arms include some locked nucleic acid (LNA) residues, but the mechanistic basis of this enhancement was not explored. Here we dissected the kinetics and thermodynamics underlying the reaction of LNA-containing 8-17 deoxyribozymes. Four 8-17 constructs were designed to target sequences within the E6 mRNA from human papillomavirus type 16. When one of these deoxyribozymes (DNAzymes) and the corresponding LNA-armed enzyme (LNAzyme) were tested against a minimal RNA substrate, they showed similar rates of substrate binding and similar rates of intramolecular cleavage, but the LNAzyme released its substrate more slowly. The superior thermodynamic stability of the LNAzyme-substrate complex led to improved performances in reactions carried out at low catalyst concentrations. The four DNAzymes and the corresponding LNAzymes were then tested against extended E6 transcripts (> 500 nucleotides long). With these structured substrates, the LNAzymes retained full activity, whereas the DNAzymes cleaved extremely poorly, unless they were allowed to pre-anneal to their targets. These results imply that LNAzymes can easily overcome the kinetic barrier represented by local RNA structure and bind to folded targets with a faster association rate as compared with DNAzymes. Such faster annealing to structured targets can be explained by a model whereby LNA monomers favor the initial hybridization to short stretches of unpaired residues ("nucleation"), which precedes disruption of the local mRNA structure and completion of the binding process.
引用
收藏
页码:35510 / 35518
页数:9
相关论文
共 43 条
[1]   Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme [J].
Bonaccio, M ;
Credali, A ;
Peracchi, A .
NUCLEIC ACIDS RESEARCH, 2004, 32 (03) :916-925
[2]  
Bondensgaard K, 2000, CHEM-EUR J, V6, P2687, DOI 10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.3.CO
[3]  
2-L
[4]   Target site selection for an RNA-cleaving catalytic DNA [J].
Cairns, MJ ;
Hopkins, TM ;
Witherington, C ;
Wang, L ;
Sun, LQ .
NATURE BIOTECHNOLOGY, 1999, 17 (05) :480-486
[5]   Catalytic DNA: A novel tool for gene suppression [J].
Cairns, MJ ;
Saravolac, EG ;
Sun, LQ .
CURRENT DRUG TARGETS, 2002, 3 (03) :269-279
[6]  
Cairns Murray J, 2004, Methods Mol Biol, V252, P267
[7]   OLIGONUCLEOTIDE INTERACTIONS .3. CIRCULAR DICHROISM STUDIES OF CONFORMATION OF DEOXYOLIGONUCLEOTIDES [J].
CANTOR, CR ;
WARSHAW, MM ;
SHAPIRO, H .
BIOPOLYMERS, 1970, 9 (09) :1059-&
[8]   Stopped-flow kinetics of lacked nucleic acid (LNA)-oligonucleotide duplex formation: studies of LNA-DNA and DNA-DNA interactions [J].
Christensen, U ;
Jacobsen, N ;
Rajwanshi, VK ;
Wengel, J ;
Koch, T .
BIOCHEMICAL JOURNAL, 2001, 354 :481-484
[9]   Preclinical anticancer activity of DNA-based cleavage molecules [J].
Dass, C .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (01) :1-5
[10]   Deoxyribozymes: cleaving a path to clinical trials [J].
Dass, CR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (08) :395-397